Thrombolytic treatment in acute ischemic stroke in a center without previous experience. Development of internal organization and first results;Tratamiento trombolítico del ictus isquémico agudo en un centro sin experiencia previa. Desarrollo de la organización interna y primeros resultados

Revista Clinica Espanola

Volumn 206, Issue 10, 2006, Pages 485-490

  Masjuan Vallejo, J ^a   Alonso de Lecinana Cases M ^a   Garcia Barragan N ^a   Zarza Sanz, B ^a   Diaz Sanchez M ^a   Martinez Castrillo J C ^a   Corral Corral, I ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Acute stroke unit; Intravenous tissue type plasminogen activator; SITS MOST; Stroke; Trombolysis

Indexed keywords

ACTYLISE; ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANAPHYLAXIS; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DETERIORATION; DOUBLE BLIND PROCEDURE; EDUCATION PROGRAM; EPISTAXIS; FEMALE; FIBRINOLYTIC THERAPY; GENERAL CONDITION IMPROVEMENT; GINGIVA BLEEDING; HEMATOMA; HEMATURIA; HOSPITAL PERSONNEL; HUMAN; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGANIZATION; OUTCOME ASSESSMENT; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL; REGISTER; SCORING SYSTEM;

EID: 33845292234     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13094896     Document Type: Article

References (33)

1. Dávalos A. Tratamiento trombolítico en el infarto cerebral agudo. Neurología. 2004;19:143-5.
2. Safe Implementation of Thrombolysis in Stroke: a Multinational Multicentre Monitoring Study of Safety and Efficacy of Thrombolysis in Stroke). Disponible en: http//www.acutestroke.org.
3. Adams H, Adams R, Del Zoppo G, Goldstein LB; Stroke Council of the American Heart Association; American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005;36:916-23.
4. European Stroke Initiative Executive Committee and Writing Committee. The European stroke initiative recommendations for stroke management. Update 2003. Cerebrovasc Dis. 2003;16:311-8.
5. Alonso de Leciñana M, Pérez-R GE, Díez-Tejedor E, en representación de la Sociedad Iberoamericana de Enfermedad Cerebrovascular (SIECV). Recomendaciones para el tratamiento y prevención del ictus, 2004. Rev Neurol. 2004;39:465-86.
6. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, et al. Improved reliability of the NIH stroke scale using video training. Stroke. 1994;25:2220-6.
7. Hacke W, Kaste M, Frieschi C, Toni D, Lesaffre E, Von Kummer R, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-51.
8. Bonita R, Beaglehole R. Modification of Rankin Scale: Recovery of motor function after stroke. Stroke. 1988;19:1497-500.
9. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
10. Inddredavik B, Bakke F, Solberg R, Rokseth R, Haaheim. LL, Holme I. Benefit of a stroke unit: a randomized controlled trial. Stroke. 1991;22:1026-31.
11. Lanhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342:395-8.
12. The stroke unit trialists' collaboration. A collaborative systematic review of the randomized trials of organizad inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151-9.
13. Stroke unit trialist Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane Review). Cochrane Library, issue 1. Oxford, UK: Update software; 2002.
14. Rudd AG, Hoffman A, Irwin P, Lowe D, Pearson MG. Stroke unit care and outcome: results from the 2001 National Sentinel Audit of Stroke (England, Wales, and Northern Ireland). Stroke. 2005;36:103-6.
15. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-7.
16. Hacke W, Brott T, Caplan L, Meier D, Fieschi C, von Kummer R, et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology. 1999; 53(Supl 4):S3-S14.
17. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute stroke (Cochrane review). The Cochrane Library, issue 3, 2001. Oxford: Update software; 2001.
18. Aboderin J, Venables G. Stroke management in Europe. Pan European Consensus Meeting on stroke management. J Intern Med, 1996;240:173-80.
19. Strandt T, Asplund K, Eriksson S, Hagg E, Lithner F, Wester PO. A non-intensive stroke unit reduces functional disability and the need for long term hospitalization. Stroke 1985;16:29-34.
20. Strandt T, Asplund K, Eriksson S, Hagg E, Lithrer F, Wester PO. Stroke unite care. Who benefits? Comparison with medical care in relation to prognostic indicators on admission. Stroke. 1986;17:377-81.
21. Lara M, Díez Tejedor E, Tatay J, Barreiro P. Duración y objetivos del ingreso hospitalario en unidades de ictus. Rev Neurol. 1997;25:1113-5.
22. Egido JA, González Gutiérrez JL, Varela de Seijas E. Experiencia de una Unidad de Ictus en el Hospital Clínico de Madrid. Rev Neurol. 1995; 23:385-9.
23. Díez-Tejedor E, Fuentes B. Acute stroke care in stroke. Do stroke units make the difference? Cerebrovasc Dis. 2001;11 (Supl 1):31-9.
24. Fuentes B, Díez-Tejedor B, Ortega-Casarrubios, Martínez P, Lara M, Frank A. Consistency of stroke units benefits within years of running. An 8-year efficacy analysis. Cerebrovasc Dis 1996;6:315-24.
25. The ATLANTIS, ECASS and NINDS rt-PA study group investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA stoke trials. Lancet. 2004;363:768-74.
26. Dávalos A, Álvarez Sabín J, Martí-Vilalta JL, Castillo J por el Registro de trombólisis del GEECV de la SEN. Tratamiento intravenoso con activador del plasminógeno tisular en la isquemia cerebral aguda. Med Clin (Barc). 2003;120:1-5.
27. Belvis R, Cocho D, Martí-Fábregas J, Pagonabarraga J, Aleu A, García-Bargo MD, et al. Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain. Cerebrovasc Dis. 2005;19:96-101.
28. Álvarez-Sabn̂ J, Molina CA, Abilleira S, Montáner J, García Alfranca F, Jiménez Fabrega X, et al. Impacto del código ictus en la eficacia del tratamiento trombolítico. Med Clin (Barc). 2003;120:47-51.
29. Gómez CR, Malkoff MD, Sauer CM, Tulyapronchote R, Burch CM, Banet GA. Code stroke. An attempt to shorten inhospital therapeutic delays. Stroke. 1994;25:1920-3.
30. Molina C, Saber JL. Extending reperfusion therapy for acute ischemic stroke. Emerging pharmacological, mechanical, and imaging strategies. Stroke. 2005;36:2311-20.
31. Pérez-Sempere A. Morbilidad por enfermedad cerebrovascular en España: Incidencia y prevalencia. Rev Neurol. 1999;29:879-81.
32. Instituto Nacional de Estadística. Defunciones según la causa de muerte 2000. Disponible en: http://www.ine.es. Fecha última consulta: 30-12-2002.
33. Egido JA, Alonso de Leciñana M, Martínez-Vila E, Díez-Tejedor E; por el Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el tratamiento del infarto cerebral agudo. En: Díez Tejedor E, editor. Guía para el diagnóstico y tratamiento del ictus. Guías oficiales de la Sociedad Española de Neurología No. 3. Barcelona: Prous Science; 2006. p. 97-132.